open access

Vol 68, No 4 (2018)
Research paper (original)
Published online: 2019-01-16
Get Citation

Estimating of the number of cancer cases attributed to HPV infections for Poland in 2015

Urszula Sulkowska, Marta Mańczuk, Krzysztof Przewoźniak, Paweł Koczkodaj, Irena Przepiórka, Magdalena Cedzyńska, Joanna Didkowska
DOI: 10.5603/NJO.2018.0028
·
Nowotwory. Journal of Oncology 2018;68(4):173-175.

open access

Vol 68, No 4 (2018)
Original article
Published online: 2019-01-16

Abstract

Introduction. Human papillomavirus (HPV) is responsible for almost all cervical cancers, for an important fraction of other anogenital cancers (anus, vulva, vagina and penis), but also for some head and neck cancer cases.

Material and method. Data on cancer incidence for Poland in 2015 were taken from the database of Polish National Cancer Registry (http://onkologia.org.pl). Attributable fractions (AFs) for all HPV-associated cancer sites were derived from published study. The number of cancer cases attributable to HPV infections was calculated by multiplying the number of registered new cancer cases by the given AF for all HPV-associated cancer sites.

Results. Of all newly registered cancer cases for Poland in the analysed year, 4080 were estimated to be attributable to HPV infections. The vast majority of these cases — 3300, were diagnosed in women, 780 in men. Cancer cases attributed to HPV represent 44% of all cancers related to HPV and 2.5% of all malignant neoplasms registered in Poland in 2015.

Conclusions. The fraction of cancers attributable to HPV infections is highly dominated by cervical cancer. Effective control of this cancer site should combine increasing awareness of threats related to HPV infections, improving access to HPV vaccination (primary prevention) by introduction of financing from public funds, and increasing access to secondary prevention in both forms — cytological and HPV testing. Introduction of an HPV vaccination population program in Poland should be a priority in strategy of cancer control.

Abstract

Introduction. Human papillomavirus (HPV) is responsible for almost all cervical cancers, for an important fraction of other anogenital cancers (anus, vulva, vagina and penis), but also for some head and neck cancer cases.

Material and method. Data on cancer incidence for Poland in 2015 were taken from the database of Polish National Cancer Registry (http://onkologia.org.pl). Attributable fractions (AFs) for all HPV-associated cancer sites were derived from published study. The number of cancer cases attributable to HPV infections was calculated by multiplying the number of registered new cancer cases by the given AF for all HPV-associated cancer sites.

Results. Of all newly registered cancer cases for Poland in the analysed year, 4080 were estimated to be attributable to HPV infections. The vast majority of these cases — 3300, were diagnosed in women, 780 in men. Cancer cases attributed to HPV represent 44% of all cancers related to HPV and 2.5% of all malignant neoplasms registered in Poland in 2015.

Conclusions. The fraction of cancers attributable to HPV infections is highly dominated by cervical cancer. Effective control of this cancer site should combine increasing awareness of threats related to HPV infections, improving access to HPV vaccination (primary prevention) by introduction of financing from public funds, and increasing access to secondary prevention in both forms — cytological and HPV testing. Introduction of an HPV vaccination population program in Poland should be a priority in strategy of cancer control.

Get Citation

Keywords

HPV, human papillomavirus, cancer, Poland, attributable fraction, primary and secondary prevention, HPV vaccine

About this article
Title

Estimating of the number of cancer cases attributed to HPV infections for Poland in 2015

Journal

Nowotwory. Journal of Oncology

Issue

Vol 68, No 4 (2018)

Article type

Research paper (original)

Pages

173-175

Published online

2019-01-16

Page views

488

Article views/downloads

526

DOI

10.5603/NJO.2018.0028

Bibliographic record

Nowotwory. Journal of Oncology 2018;68(4):173-175.

Keywords

HPV
human papillomavirus
cancer
Poland
attributable fraction
primary and secondary prevention
HPV vaccine

Authors

Urszula Sulkowska
Marta Mańczuk
Krzysztof Przewoźniak
Paweł Koczkodaj
Irena Przepiórka
Magdalena Cedzyńska
Joanna Didkowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl